Barrett's oesophagus:: from metaplasia to dysplasia and cancer

被引:89
|
作者
Fléjou, JF [1 ]
机构
[1] CHU St Antoine, Hop Paris, Serv Anat Pathol, F-75571 Paris, France
关键词
D O I
10.1136/gut.2004.041525
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Barrett's oesophagus is a premalignant condition that predisposes to the development of oesophageal adenocarcinoma. it is detected on endoscopy and confirmed histologically by the presence in the lower oesophagus of a metaplastic mucosa, the so-called specialised epithelium, which resembles incomplete intestinal metaplasia in the stomach. These similarities with incomplete intestinal metaplasia are present on histology, mucin histochemistry, and immunohistochemistry with various differentiation markers (cytokeratins and MUC antigens). On morphology, the carcinogenetic process of Barrett's mucosa progresses through increasing grades of epithelial dysplasia. Dysplasia, a synonym of intraepithelial neoplasia, is the only marker that can be used at the present time to delineate a population of patients at high risk of cancer. Among the numerous molecular events that have been shown to play a role in the neoplastic transformation of Barrett's mucosa, only changes in DNA ploidy, increased proliferation, and alterations of the p53 gene have been suggested to be of potential help in the surveillance of patients.
引用
收藏
页码:I6 / I12
页数:7
相关论文
共 50 条
  • [1] Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus
    Sharma, P
    Weston, AP
    Topalovski, M
    Cherian, R
    Bhattacharyya, A
    Sampliner, RE
    [J]. GUT, 2003, 52 (01) : 24 - 27
  • [2] Intestinal metaplasia in Barrett's oesophagus: An essential factor to predict the risk of dysplasia and cancer development
    Salemme, Marianna
    Villanacci, Vincenzo
    Cengia, Gianpaolo
    Cestari, Renzo
    Missale, Guido
    Bassotti, Gabrio
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (02) : 144 - 147
  • [3] Expression analysis of the metaplasia dysplasia carcinoma sequence in Barrett's oesophagus and adenocarcinoma
    Penman, ID
    Smith, V
    Shen, EF
    Wieand, D
    Landon, TH
    Wong, NACS
    Lessells, AM
    Paterson-Brown, S
    Tang, JZ
    Wu, T
    Hillan, KJ
    [J]. GUT, 2003, 52 : A7 - A7
  • [4] Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk
    Kelty, Clive J.
    Gough, Martin D.
    Van Wyk, Quintin
    Stephenson, Timothy J.
    Ackroyd, Roger
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (11) : 1271 - 1274
  • [5] Barrett's oesophagus: Frequency and prediction of dysplasia and cancer
    Falk, Gary W.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (01) : 125 - 138
  • [6] Expression of cox-2 links Barrett's metaplasia, dysplasia and adenocarcinoma in the oesophagus
    Bhandari, P
    Johnson, P
    Bateman, A
    Patel, P
    [J]. GUT, 2001, 48 : A29 - A30
  • [7] Crypt dysplasia on Barrett's oesophagus
    Baldaque-Silva, Francisco
    Marques, Margarida
    Lopes, Joanne
    Carneiro, Fatima
    Vieth, Michael
    Macedo, Guilherme
    [J]. GUT, 2014, 63 (03) : 528 - 529
  • [8] Dysplasia in patients with Barrett's oesophagus
    Mikchaleva, L.
    Voytkovskaya, K.
    Fedorov, E.
    Shidiy-Zakrua, A.
    [J]. VIRCHOWS ARCHIV, 2020, 477 : S190 - S190
  • [9] Incidence of dysplasia in Barrett's oesophagus
    Mikhaleva, L.
    Maslenkina, K.
    Gusniev, S.
    Olesya, V.
    Gioeva, Z.
    [J]. VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S218 - S219
  • [10] Genomic biomarkers of Barrett's Oesophagus metaplasia, dysplasia and malignant progression: a meta-analysis
    Findlay, John
    Middleton, Mark
    Tomlinson, Ian
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 : 39 - 39